abstract |
THE INVENTION RELATES TO THE FIELD OF PHARMACEUTICAL CHEMISTRY. IT CONCERNS A NEW PHARMACEUTICAL COMPOSITION CONTAINING IN ASSOCIATION OF ANAGRELIDE, THAT IS TO SAY 6,7-DICHLORO-1,5-DIHYDROIMIDAZO 2,1-B QUINAZOLINE-2 (3H) -ONE AND A QUANTITY , CAPABLE OF ENHANCING THE ACTIVITY OF THIS SUBSTANCE, OF A NON-STEROIDIC ANTI-INFLAMMATORY AGENT CHOSEN FROM THE GROUP CONSISTING OF ACETYLSALICYLIC ACID, ZOMEPIRAC, IBUPROFENE, NAPROXENE, SULFINPETHYRAZINE AND PHOINDUOMINE . THE OVERADDITIVE EFFECTS OF THE NEW ASSOCIATIONS ACCORDING TO THE INVENTION ALLOWS THE COMPOSITIONS CONTAINING THEM TO BE USED IN THE THERAPEUTIC AND PROPHYLACTIC TREATMENT OF THROMBOSIS AND OTHER DISORDERS ASSOCIATED WITH AGGREGATION OF BLOOD PLATES. |